By selecting the Yes option, Leave Amgen.co.uk option, you understand that you are leaving the corporate page of Amgen UK and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.

The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.

yes, leave amgen.co.uk CANCEL

At Amgen, our mission is to serve patients. As a science-based, patient-focused organisation, we discover and develop innovative therapies to treat serious illnesses. Our medicines have made a dramatic difference in the lives of millions.

Amgen is committed to patient safety and continually monitors the safety and quality of our products. If you want to contact Amgen for any of the following reasons, please call us on +44 (0)1223 436441 and provide us with the details:

  • You think you may have experienced a side effect (‘adverse event’) after taking or using an Amgen product.
  • You think there may be a defect or quality issue with the Amgen product you have received.
  • You have a general medical information enquiry about your Amgen product.

If you do have any side effects, talk to your healthcare professional. This includes any possible side effects not listed in the package leaflet.

If you are in the United Kingdom (England, Scotland, Wales and Northern Ireland), you can report side effects or product defects directly to the Medicines and Healthcare products Regulatory Agency (MHRA).

To read more about the Falsified Medicines Directive and the impact this may have on Amgen packaging, click here.

Below you will find information on Amgen’s product portfolio. The Summary of Product Characteristics and patient information leaflets for each product can be accessed via the links. These links direct you to the Electronic Medicines Compendium (eMC) websites and provide information about all medicines available in the United Kingdom.

Please note that this information is specific to the United Kingdom Click here to read our Terms and Conditions of Sale.

By reporting side effects, you can help provide more information on the safety of our medicines.

Side effect reporting information can be found at http://yellowcard.mhra.gov.uk/

▼This product is subject to additional monitoring, which will allow quick identification of new safety information.

Job Code: GBR-NP-0924-80009
Date of preparation: January 2025